arrow_back Back to App

September 2025: Sickle Cell Disease Awareness Month

The U.S. Senate supports designating September 2025 as Sickle Cell Disease Awareness Month. The goal is to educate communities about the disease, including early detection, effective treatments, and preventive care programs. This initiative aims to help citizens better understand the condition and access information about available treatments.
Key points
Increasing public awareness of sickle cell disease, its symptoms, and consequences.
Promoting research, early detection, and access to new, effective treatments, including gene therapies.
Encouraging the organization of educational events to inform about the disease and support patients.
article Official text account_balance Process page
Adopted
Citizen Poll
No votes cast
Additional Information
Print number: 119_SRES_416
Sponsor: Sen. Scott, Tim [R-SC]
Process start date: 2025-09-19
Lustra uses Artificial Intelligence. Verify details in source documents.
Summarized by: gemini-2.5-flash-preview-05-20
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

A resolution expressing support for the designation of September 2025 as "Sickle Cell Disease Awareness Month" in order to educate communities across the United States about sickle cell disease and the need for research, early detection methods, effective treatments, and preventative care programs with respect to complications from sickle cell disease and conditions related to sickle cell disease.

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 119_SRES_416.

Which chamber initiated this legislation?

This legislation was initiated in the Senate.

When did the legislative process begin?

The process officially started on 2025-09-19.

What are the main provisions?

Key points include:

  • Increasing public awareness of sickle cell disease, its symptoms, and consequences.
  • Promoting research, early detection, and access to new, effective treatments, including gene therapies.
  • Encouraging the organization of educational events to inform about the disease and support patients.
What is the specific legal status?

The current status is Adopted.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Sen. Scott, Tim [R-SC].

What is the latest detailed status?

The latest detailed status is: Submitted in the Senate, considered, and agreed to without amendment and with a preamble by Unanimous Consent. (consideration: CR S6798; text: CR S6795)

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-23.

CATEGORIES

Health